Announcement • Feb 10
PetVivo Holdings, Inc. to Report Q3, 2026 Results on Feb 17, 2026 PetVivo Holdings, Inc. announced that they will report Q3, 2026 results on Feb 17, 2026 Announcement • Jan 15
PetVivo Holdings, Inc. Announces Resignation of Director Michael Eldred, Effective January 9, 2026 PetVivo Holdings, Inc. announced that on January 9, 2026, the Board of Directors recognized the resignation of Michael Eldred as a member of the Company's Board of Directors, effective as of that date (January 9, 2026). The Board of Directors determined to reduce the size of the Board from eight directors to seven directors, and the resulting vacancy created by the resignation will not be filled at this time. Announcement • Nov 25
PetVivo Holdings, Inc. Launches Ai Platform Reducing Veterinary Client Acquisition Costs by 50-89% PetVivo Holdings, Inc. in cooperation with its wholly owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc. announced the launch of PetVivo.ai, a new artificial intelligence platform delivering a customer acquisition cost of $42.53--a 50-89% reduction compared to the $80-$400 typically spent by veterinary practices. The platform generates qualified leads for $3 per pet parent (versus $15-$45 through traditional digital advertising) and uses automated AI engagement to convert these leads into paying customers. This launch marks a major strategic move for PetVivo Holdings as the company expands from traditional medical device sales--hist historically generating 30-40% margins-- into a high-margin AI Software-as-a-Service (SaaS) model with 80-90% margins, recurring revenue, and significant scalability. Although the pet care industry now exceeds $150 billion annually, veterinary practices face a widening gap in how they reach today's pet owners. Gen Z and Millennial pet parents account for 57% of all pet owners and expect modern digital experiences, yet many practices still depend on outdated marketing methods such as TV advertising and direct mail. PetVivo.ai solves this problem through a suite of nine specialized AI agents operating continuously: Client Discovery, Campaign Manager, Engagement, Analytics, Content Creation, Reputation, Compliance, ROI Optimization, and Practice Integration. Together, these agents connect practices with millions of engaged pet parents through a two-sided ecosystem. The platform's economics were validated in a 50-practice beta program: Lead Generation: $3 per qualified pet parent (vs. $15-$45 traditional); Customer Acquisition Cost: $42.53 blended CAC (vs. $80-$400 typical); Beta Results: 47 new clients median over 6 months (range: 12-124); Pricing: $1,999/month for the Professional tier; LTV/CAC Ratio: 25:1 (best-in-class); Payback Period: 1 month; Gross Margins: 80-90% Market Opportunity. PetVivo.ai targets 30,000 U.S. veterinary practices and more than 100,000 globally. Even conservative adoption forecasts indicate strong scaling potential: Year 1: 500 practices - $12 million ARR; Year 3: 5,000 practices - $180 million ARR; Year 5: 10,000 practices - $360 million ARR. The Catalyst: The launch serves as a major catalyst for re-valuing the company as it transitions from traditional medical device revenue multiples (1-2x revenue) to AI SaaS multiples (15-30x revenue). Comparable companies such as Salesforce, HubSpot, Veeva Systems, and C3.ai trade at median multiples near 15x, suggesting potential 5-10x valuation upside as PetVivo.ai scales. 
